Regencell Bioscience Holdings Limited (RGC) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Drug Manufacturers - Specialty & Generic उद्योग. कंपनी का मुख्यालय है Causeway Bay, Hong Kong. वर्तमान CEO हैं Yat-Gai Au.
RGC के पास है IPO तिथि 2021-07-16, 12 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Capital Marke, बाजार पूंजीकरण $14.89B.
Regencell Bioscience Holdings Limited is a Traditional Chinese medicine bioscience company incorporated in 2014 and headquartered in Causeway Bay, Hong Kong. The company specializes in the research, development, and commercialization of TCM-based treatments for neurocognitive disorders and degeneration, with a primary focus on attention deficit hyperactivity disorder and autism spectrum disorder. Through its integrated approach to traditional medicine and modern science, Regencell aims to address significant unmet medical needs in neurological health.
